摘要
目的:观察关节腔内及膝周痛点注射富血小板血浆治疗膝关节骨性关节炎的临床疗效,并分析其安全性和可行性。方法:将2017年1月至12月收治的膝关节骨性关节炎患者48例分为观察组和对照组,每组24例。观察组男8例,女16例;年龄43~68(58.04±7.87)岁,病程1~8(4.69±1.96)年;身体质量指数(24.53±5.26) kg/m^2;给予关节腔内注射富血小板血浆2 ml,膝周痛点注射富血小板血浆共2 ml,1次/周,共治疗3次;对照组男7例,女17例;年龄47~72(60.54±8.93)岁;病程1.5~9(5.27±1.68)年;身体质量指数(23.47±4.62) kg/m^2;给予关节腔内注射透明质酸钠20 mg,膝周痛点封闭治疗,每点2 ml药液,1次/周,共治疗3次。记录并比较两组患者治疗前、治疗后1个月及6个月VAS评分和Lysholm评分以进行疗效评估。结果:48例患者均获6个月随访,未发生严重不良反应或并发症。观察组与对照组治疗前、治疗后1和6个月VAS评分分别为7.35±1.47,4.15±1.52,2.26±1.02和7.51±1.39,3.84±1.76,3.66±1.18;治疗后6个月,观察组VAS评分低于对照组(P<0.05)。观察组与对照组治疗前、治疗后1和6个月Lysholm评分分别为55.21±5.78,79.16±7.25,85.45±6.87和54.65±6.40,77.58±6.94,82.34±7.12;两组治疗后总分均较治疗前明显改善(P<0.05);治疗后1个月,两组总分比较差异无统计学意义(P>0.05);治疗后6个月,观察组总分优于对照组(P<0.05)。结论:关节腔内及膝周痛点注射富血小板血浆疗法可有效缓解膝关节疼痛,改善膝关节功能,同时安全性较高,虽短期疗效与传统治疗方法无明显差别,但中远期疗效稳定,是一种安全有效治疗膝关节骨性关节炎的方法。
Objective:To observe clinical effects of platelet-rich plasma(PRP) intra-articular and extra-articular injection for patients with knee osteoarthritis(KOA),and analyze its safety and clinical efficacy.Methods:From January to December2017,48 patients with KOA were randomly divided into observation group and control group,24 cases in each group.The observation group was treated with intra-articular injection of PRP(2 ml) and extra-articular injection of PRP(2 ml),once a week,for three times,including 8 males and 16 females with an average of(58.04±7.87) years old ranging from 43 to 68 years old,the courses of disease ranged from 1 to 8 years with an average of(4.69±1.96) years,the body mass index(BMI) was(24.53±5.26) kg/m2.The control group was treated with intra-articular injection of sodium hyaluronate(20 mg),extra-articular injection of analgesic drug(2 ml for one point),once a week,for three times,including 7 males and 17 females with an average of(60.54±8.93) years old ranging from 47 to 72 years old,the courses of disease ranged from 1.5 to 9 years with an average of(5.27±1.68) years,BMI was(23.47±4.62) kg/m2.VAS score and Lysholm score before operation and the 1 st,6 th month after treatment were compared between two groups.Results:All patients were followed up at least 6 months without occurrence serious adverse reactions or complications.VAS score in observation group and control group before treatment and 1 st,6 th month after treatment were 7.35±1.47,4.15±1.52,2.26±1.02 and 7.51±1.39,3.84±1.76,3.66±1.18,respectively;VAS score in obsevation group was lower than that of control group at 6 months after treatment.Lysholm score in observation group and control group before treatment and 1 st,6 th month after treatment were 55.21±5.78,79.16±7.25,85.45±6.87 and 54.65±6.40,77.58±6.94,82.34±7.12.There were significant differences in Lysholm score before and after injection between two groups(P<0.05).There was no significant difference in Lysholm score between two groups at 1 month after treatmen
作者
杜薇
崔洪鹏
付本升
李雯
刘倩
钟毓贤
董妍含
DU Wei;CUI Hong-peng;FU Ben-sheng;LI Wen;LIU Qian;ZHONG Yu-xian;DONG Yan-han(Department of Rehabilitation,the Sixth Medical Center of PLA General Hospital,Beijing 100048,China)
出处
《中国骨伤》
CAS
CSCD
2020年第3期209-213,共5页
China Journal of Orthopaedics and Traumatology
关键词
骨关节炎
膝
富血小板血浆
注射
关节内
Osteoarthritis,knee
Platelet-rich plasma
Injections,intra-articular